ADMETGPT provides an AI-powered platform for drug discovery teams to predict absorption, distribution, metabolism, excretion, and toxicity properties of molecules using transformer models. The service enables biotech, pharmaceutical, and academic users to screen molecular libraries and generate detailed safety and property reports through a web interface or API. It is designed to assist in optimizing drug candidates and reducing laboratory assay costs.
AI named ADMETGPT in June 2026.
AI cited admetgpt.com in these answers, after admetron.partex.ai, certara.com, and deepcyte.bio.
admetgpt.com 9%Other sites 91%